1395346-28-7: Deferasirox Salicyloyl Ester

Status: In-stock

Deferasirox Salicyloyl Ester Cas No. 1395346-28-7 with IUPAC Name 4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid is an impurity of Deferasirox which is mainly used to reduce chronic iron overload in patients receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. The first oral medication approved in the United States for this purpose is Deferasirox.

Request quotation

Additional information on CAS 1395346-28-7

Catalogue No. VE008731
CAS No. 1395346-28-7
Molecular Formula C28H19N3O6
Molecular Weight 493.5 g/mol
Parent drug Deferasirox
IUPAC Name 4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1, 2, 4-triazol-1-yl)benzoic acid
Synonyms N/A
References Choudhry, V. P., and Rahul Naithani. “Current Status of Iron Overload and Chelation with Deferasirox.” The Indian Journal of Pediatrics, vol. 74, no. 8, Aug. 2007, pp. 759–64, https://doi.org/10.1007/s12098-007-0134-7.
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1395346-28-7: Deferasirox Salicyloyl Ester

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden
This field is for validation purposes and should be left unchanged.